Gut Microbiome Transplant Eases Lung Infection in Hypoxia Study

A new study published in PLOS ONE has found that faecal microbiota transplantation (FMT) can significantly reduce respiratory infection severity in rats exposed to high-altitude, low-oxygen conditions — offering fresh evidence for the gut-lung axis as a therapeutic target. Conducted by researchers including Huan Wang and colleagues, the study exposed rats to simulated high-altitude conditions of 5,000 metres for 14 days before infecting them with Streptococcus pneumoniae, then treating them with FMT.

Why This Matters

The gut-lung axis — the two-way communication between gut microbiome communities and lung immunity — is an emerging focus in microbiome UK research and globally. Scientists have long understood that disruption to the gut microbiota can impair immune defences beyond the digestive tract, but evidence linking specific gut interventions directly to lung protection has remained limited. This study adds to a growing body of work suggesting that gut health is not merely a digestive concern but a whole-body one, with implications that could one day inform NHS gut health strategies and respiratory care pathways.

FMT Reduced Inflammation and Improved Immune Response

According to the researchers, hypobaric hypoxia — the low air pressure and reduced oxygen found at high altitude — triggered measurable disruption to the rats' gut microbiota and reduced levels of short-chain fatty acids (SCFAs) in the bloodstream. FMT treatment was found to suppress NLRP3 inflammasome activity, lower pro-inflammatory cytokine levels, reduce bacterial load in the lungs, and increase secretory IgA (sIgA), a key component of mucosal immunity. The study used 16S rRNA sequencing and gas chromatography–mass spectrometry (GC-MS) to characterise microbial and metabolic changes, per the published findings in PLOS ONE.

What This Means for Gut and Respiratory Health

While this research was conducted in rats and cannot be directly translated to human treatment, the findings support the broader scientific case for improving gut health naturally as a means of bolstering systemic immunity. For the UK public — where respiratory infections such as pneumonia account for significant NHS hospital admissions each winter — understanding how gut microbiome health shapes lung defence could open new avenues for both prevention and treatment. Researchers suggest FMT modulates the immune system through the gut-lung axis, pointing to microbiome-targeted therapies as a viable future direction.

The study is particularly relevant in the context of expanding UK microbiome research, with institutions such as King's College London and the University of Reading actively investigating how gut bacteria influence immune outcomes. The gut-brain connection has attracted considerable public and scientific attention in recent years, but this research underscores that the microbiome's reach extends to the lungs as well.

As interest in the British diet gut health link grows — supported by initiatives such as the British Gut Project — findings like these reinforce why maintaining a diverse, fibre-rich diet that nurtures beneficial gut bacteria may have consequences far beyond the digestive system.

You might also like

• How to Boost GLP-1 Naturally for Gut Health
• How to Improve Gut Health Naturally (No Fad Diets)
• Gut-Brain Connection & Psychedelics: Your Questions Answered

96 Bacterial Strains. Two Shots a Day.

GOODIE is an award-winning fermented drink with 96 live bacterial strains — more than any yogurt or kombucha — never pasteurised, clinically tested, and 8 in 10 users felt less bloating within 14 days. Curious?

Find out more →